JOHNSON & JOHNSON Long-Term Concentrated

Location: New Brunswick, NJ

CIK: 0000200406 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 10, 2022

Total Value: $340M (100.0% shares, 0.0% debt)

Holdings (22)

FATE Fate Therapeutics, Inc. 22.3%

Value $75.72M Shares 3,379,064 Est. Cost $78.44 Unrealized -63.2%

LEGN Legend Biotech Corporation 19.6%

Value $66.47M Shares 1,629,173 Est. Cost $50.56 Unrealized —

PRCT Procept BioRobotics Corporation 10.5%

Value $35.82M Shares 863,908 Est. Cost $38.38 Unrealized +3.9%

CVRX CVRx, Inc. 9.6%

Value $32.61M Shares 3,495,575 Est. Cost $19.18 Unrealized -58.7%

MGTX MeiraGTx Holdings plc 7.2%

Value $24.38M Shares 2,898,550 Est. Cost $13.69 Unrealized -35.6%

PTGX Protagonist Therapeutics Inc. 6.1%

Value $20.65M Shares 2,449,183 Est. Cost $42.63 Unrealized -77.8%

XNCR Xencor, Inc. 5.7%

Value $19.43M Shares 748,062 Est. Cost $37.91 Unrealized -24.5%

HLTHQ Cue Health, Inc. 4.9%

Value $16.7M Shares 5,548,864 Est. Cost $11.81 Unrealized —

— Fusion Pharmaceuticals Inc. 3.3%

Value $11.05M Shares 3,670,516 Est. Cost $7.92 Unrealized —

— Adicet Bio, Inc. 3.1%

Value $10.37M Shares 728,944 Est. Cost $7.84 Unrealized —

ARWR Arrowhead Pharmaceuticals, Inc. 2.4%

Value $8.183M Shares 247,598 Est. Cost $64.75 Unrealized -37.7%

— Point Biopharma Global Inc. 2.3%

Value $7.73M Shares 1,000,000 Est. Cost $7.69 Unrealized —

— Vor Biopharma, Inc. 1.3%

Value $4.277M Shares 1,074,658 Est. Cost $15.68 Unrealized —

NNOX Nano-X Imaging Ltd. 0.6%

Value $2.207M Shares 192,429 Est. Cost $20.72 Unrealized -37.9%

ALDX Aldeyra Therapeutics, Inc. 0.6%

Value $2.108M Shares 394,834 Est. Cost $9.18 Unrealized -34.6%

— SomaLogic, Inc. 0.2%

Value $815K Shares 281,052 Est. Cost $12.39 Unrealized —

— BiomX Inc. 0.2%

Value $725K Shares 2,133,402 Est. Cost $3.06 Unrealized —

— PhaseBio Pharmaceuticals, Inc. 0.1%

Value $283K Shares 1,607,044 Est. Cost $3.11 Unrealized —

— Tracon Pharmaceuticals, Inc. 0.0%

Value $140K Shares 84,003 Est. Cost $3.87 Unrealized —

— Senseonics Holdings, Inc. 0.0%

Value $72,000 Shares 54,621 Est. Cost $3.39 Unrealized —

— Graybug Vision, Inc. 0.0%

Value $47,000 Shares 49,547 Est. Cost $3.31 Unrealized —

— Catalyst Biosciences, Inc. 0.0%

Value $34,000 Shares 66,951 Est. Cost $4.11 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
FATE	Fate Therapeutics, Inc.	3,379,064	$75.72M	22.3%	$78.44	-63.2%	COM	31189P102
LEGN	Legend Biotech Corporation	1,629,173	$66.47M	19.6%	$50.56	—	ADS	52490G102
PRCT	Procept BioRobotics Corporation	863,908	$35.82M	10.5%	$38.38	+3.9%	COM	74276L105
CVRX	CVRx, Inc.	3,495,575	$32.61M	9.6%	$19.18	-58.7%	COM	126638105
MGTX	MeiraGTx Holdings plc	2,898,550	$24.38M	7.2%	$13.69	-35.6%	COM	G59665102
PTGX	Protagonist Therapeutics Inc.	2,449,183	$20.65M	6.1%	$42.63	-77.8%	COM	74366E102
XNCR	Xencor, Inc.	748,062	$19.43M	5.7%	$37.91	-24.5%	COM	98401F105
HLTHQ	Cue Health, Inc.	5,548,864	$16.7M	4.9%	$11.81	—	COM	229790100
—	Fusion Pharmaceuticals Inc.	3,670,516	$11.05M	3.3%	$7.92	—	COM	36118A100
—	Adicet Bio, Inc.	728,944	$10.37M	3.1%	$7.84	—	COM	007002108
ARWR	Arrowhead Pharmaceuticals, Inc.	247,598	$8.183M	2.4%	$64.75	-37.7%	COM	04280A100
—	Point Biopharma Global Inc.	1,000,000	$7.73M	2.3%	$7.69	—	COM	730541109
—	Vor Biopharma, Inc.	1,074,658	$4.277M	1.3%	$15.68	—	COM	929033108
NNOX	Nano-X Imaging Ltd.	192,429	$2.207M	0.6%	$20.72	-37.9%	ORD SHS	M70700105
ALDX	Aldeyra Therapeutics, Inc.	394,834	$2.108M	0.6%	$9.18	-34.6%	COM	01438T106
—	SomaLogic, Inc.	281,052	$815K	0.2%	$12.39	—	COM	83444K105
—	BiomX Inc.	2,133,402	$725K	0.2%	$3.06	—	COM	09090D103
—	PhaseBio Pharmaceuticals, Inc.	1,607,044	$283K	0.1%	$3.11	—	COM	717224109
—	Tracon Pharmaceuticals, Inc.	84,003	$140K	0.0%	$3.87	—	COM	89237H209
—	Senseonics Holdings, Inc.	54,621	$72,000	0.0%	$3.39	—	COM	81727U105
—	Graybug Vision, Inc.	49,547	$47,000	0.0%	$3.31	—	COM	38942Q103
—	Catalyst Biosciences, Inc.	66,951	$34,000	0.0%	$4.11	—	COM	14888D208